Facebook
Britain's News Portal
Around The Clock
BREAKING
Loading latest headlines…

Usher syndrome 2A diagnosis sparks hope for gene‑editing therapy

A five‑year‑old in Melbourne was diagnosed with Usher syndrome type 2A, a rare condition that causes hearing loss and progressive vision loss. Scientists at the Centre for Eye Research Australia are developing an RNA‑editing platform, EDITRA, that could correct the genetic defect with a single eye injection.

  • Usher syndrome type 2A causes hearing loss and progressive vision loss in about 1 in 6,000 children.
  • The diagnosis was confirmed by genetic testing in 2026.
  • Researchers at CERA are developing EDITRA, an RNA‑editing platform that may correct the mutation in a single injection.

A five‑year‑old in Melbourne was diagnosed with Usher syndrome type 2A, a rare inherited condition that causes hearing loss and progressive vision loss. The diagnosis was confirmed by genetic testing in 2026, when the family learned the child’s hearing loss was linked to a specific genetic mutation. The condition is the leading cause of deafblindness in Australia and affects about 1 in 6,000 children.

Researchers at the Centre for Eye Research Australia (CERA) are working on a new RNA‑editing platform called EDITRA. The platform aims to fix the tiny spelling mistake in the faulty gene that causes vision loss, delivering the treatment to the eye in a single injection. The therapy is still in the laboratory stage but could, if successful, allow children with Usher syndrome 2A to preserve their sight.

Related Articles

Get the news that matters.

Join thousands of readers getting the best of British news straight to their inbox.